Kapil Bharti

This inventor holds 12 USPTO granted patents and 11 published patent applications and 5 EPO patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Eyestem Research Private Limited, Fujifilm Cellular Dynamics, Inc.. Active years: 2019-2026.

USPTO Granted Patents = 12 (Patent Applications = 11)

% Patents Active = 100.0

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 7(Granted Patents)

Location History:

Potomac, MS (US) (2022)
Bethesda, MD (US) (2023)
Potomac, MD (US) (2019 - 2024)

Company Filing History:

11 out of 3,690

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

1 out of 2

Eyestem Research Private Limited

patents

1 out of 23

Fujifilm Cellular Dynamics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2019-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12718601 - Using machine learning and/or neural networks to validate stem cells and their derivatives (2-D cells and 3-D tissues) for use in cell therapy and tissue engineered products (2026-08-25),

2. 12674204 - METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCs) (2026-07-07),

3. 12605156 - Tissue clamp and implantation method (2026-04-21),

4. 12065671 - Method for reproducible differentiation of clinical-grade retinal pigment epithelium cells (2024-08-20),

5. 12020494 - Using machine learning and/or neural networks to validate stem cells and their derivatives (2-D cells and 3-D tissues) for use in cell therapy and tissue engineered products (2024-06-25),

6. 11819020 - Devices for tissue cryopreservation and recovery (2023-11-21),

7. 11717298 - Tissue clamp and implantation method (2023-08-08),

8. 11531844 - Using machine learning and/or neural networks to validate stem cells and their derivatives (2-D cells and 3-D tissues) for use in cell therapy and tissue engineered products (2022-12-20),

9. 11458225 - 3D vascularized human ocular tissue for cell therapy and drug discovery (2022-10-04),

10. 11441184 - Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (IPSCs) (2022-09-13),

11. 11168301 - Method for producing photoreceptor cells, retinal pigmented epithelial cells, and retinal organoids (2021-11-09),

12. 10480031 - Method for generating Retinal Pigment Epithelium (RPE) cells from Induced Pluripotent Stem Cells (IPSCs) (2019-11-19),

Title: Kapil Bharti: Innovator in Stem Cell Research

Introduction

Kapil Bharti is a prominent inventor based in Potomac, MD, known for his significant contributions to the field of stem cell research. With a total of nine patents to his name, he has made remarkable advancements in the differentiation of retinal pigment epithelium cells and the application of machine learning in cell therapy.

Latest Patents

One of his latest patents is a method for reproducible differentiation of clinical-grade retinal pigment epithelium cells. This method involves producing an RPE cell population from a starting cell suspension of pluripotent stem cells. The process includes culturing the starting single cell suspension in differentiation media to generate human RPE cells. Another notable patent focuses on using machine learning and neural networks to validate stem cells and their derivatives for use in cell therapy and tissue-engineered products. This method allows for non-invasive prediction of characteristics of cells and cell derivatives, enhancing the reliability of clinical preparations.

Career Highlights

Kapil has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Fujifilm Cellular Dynamics, Inc. His work in these institutions has significantly influenced the landscape of stem cell research and its applications.

Collaborations

Throughout his career, Kapil has collaborated with notable colleagues, including Nathan A Hotaling and Nicholas J Schaub. These collaborations have further enriched his research and innovation efforts.

Conclusion

Kapil Bharti's contributions to stem cell research and his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in cell therapy and regenerative medicine.